Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  American Journal of Pathology

• Publication date

  1998-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0002-9440(10)65690-8PMID 9846966PMCID PMC2233978
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular analysis of p53 gene in laryngeal premalignant and malignant lesions. p53 protein immunohistochemical expression is positively related to proliferating cell nuclear antigen labelling index

  2004cited by this paper
• Rb and @16@4a Expression in Resected Non-Small Cell Lung Tumors'

  2000cited by this paper
• Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.

  1999cited by this paper
• The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

  1998cited by this paper
• Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene.

  1998cited by this paper
• Frequent p161NK4 (MTS1) Gene Inactivation in Testicular Germ Cell Tumors

  1998cited by this paper
• ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

  1998cited by this paper
• Prognostic value of the immunohistochemical detection of p16[INK4] expression in nonsmall cell lung carcinoma

  1998cited by this paper
• Frequent p16INK4 (MTS1) gene inactivation in testicular germ cell tumors.

  1997cited by this paper
• Alterations of P16 (MTS1) in node‐positive non‐small cell lung carcinomas

  1997cited by this paper
• Frequent loss of heterozygosity in early non‐small cell lung cancers at chromosome 9p21 proximal to the CDKN2a gene

  1997cited by this paper
• Mdm2: keeping p53 under control

  1997influential reference
• Prognostic value of the immunohistochemical detection of p16INK4 expression in nonsmall cell lung carcinoma

  1997cited by this paper
• Advances in the understanding of lung cancer.

  1997cited by this paper
• Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma.

  1997influential reference
• E2F: a nodal point in cell cycle regulation.

  1997cited by this paper
• Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.

  1997cited by this paper
• Splicing into senescence: the curious case of p16 and p19ARF.

  1997cited by this paper
• The mdm2 proto-oncogene.

  1997cited by this paper
• G1 control gene status is frequently altered in resectable non‐small cell lung cancer

  1997influential reference
• DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.

  1997cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• Immunohistochemical and molecular evaluation of the mdm-2 gene product in bronchogenic carcinoma.

  1996cited by this paper
• Inversely correlated expression of p16 and Rb protein in non‐small cell lung cancers: An immunohistochemical study

  1996cited by this paper
• Analysis of the proportion of p53 bound to mdm-2 in cells with defined growth characteristics.

  1996cited by this paper
• Rb and p16INK4a expression in resected non-small cell lung tumors.

  1996cited by this paper
• Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity.

  1996cited by this paper
• Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies.

  1996cited by this paper
• Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers.

  1996cited by this paper
• Lessons from Hereditary Review Colorectal Cancer

  1996cited by this paper
• Intragenic mutations of the p16INK4, p15INK4B and p18 genes in primary non‐small‐cell lung cancers

  1996cited by this paper
• High frequency of aberrant p16(INK4A) expression in human breast cancer.

  1996cited by this paper
• A MOLECULAR AND IMMUNOHISTOCHEMICAL STUDY OF THE MDM2 PROTEIN ISOFORMS AND p53 GENE PRODUCT IN BRONCHOGENIC CARCINOMA

  1996cited by this paper
• Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16

  1995cited by this paper
• Down regulation of talin alters cell adhesion and the processing of the α5β1 integrin

  1995cited by this paper
• Interaction between the retinoblastoma protein and the oncoprotein MDM2

  1995influential reference
• Alterations of CDKN2 (p16) in non‐small cell lung cancer

  1995cited by this paper
• Increased p16 levels correlate with pRb alterations in human urothelial cells.

  1995cited by this paper
• Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.

  1995cited by this paper
• Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.

  1995cited by this paper
• Localisation of the human gene encoding the cytoskeletal protein talin to chromosome 9p

  1995cited by this paper
• Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.

  1995cited by this paper
• Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.

  1995cited by this paper
• Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage.

  1995cited by this paper
• Loss of heterozygosity at 9p21 loci and mutations of the MTS1 and MTS2 genes in human lung cancers

  1995cited by this paper
• Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers.

  1995influential reference
• In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers.

  1995cited by this paper
• Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.

  1995cited by this paper
• 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

  1995cited by this paper
• Down regulation of talin alters cell adhesion and the processing of the alpha 5 beta 1 integrin.

  1995cited by this paper
• Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma.

  1995cited by this paper
• CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine.

  1995cited by this paper
• Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21.

  1995cited by this paper
• Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer.

  1995cited by this paper
• Growth suppression by p16ink4 requires functional retinoblastoma protein.

  1995cited by this paper
• Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer.

  1995cited by this paper
• IS-12 Mutation and altered expression of P16^ in human cancer.

  1995cited by this paper
• mdm2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations.

  1995cited by this paper
• Microsatellite instability and other molecular abnormalities in non-small cell lung cancer.

  1995cited by this paper
• Rates of p16 (MTS1) mutations in primary tumors with 9p loss.

  1994cited by this paper
• Genetic instability of microsatellite sequences in many non-small cell lung carcinomas.

  1994cited by this paper
• p53, guardian of Rb

  1994cited by this paper
• Biology of lung cancer.

  1994cited by this paper
• Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4.

  1994cited by this paper
• Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

  1994cited by this paper
• Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck.

  1994cited by this paper
• Frequent microsatellite instability in primary small cell lung cancer.

  1994cited by this paper
• Cooperative tumorigenic effects of germline mutations in Rb and p53

  1994cited by this paper
• Altered patterns of MDM2 and TP53 expression in human bladder cancer.

  1994cited by this paper
• Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti‐RB antibodies

  1994cited by this paper
• Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB.

  1994cited by this paper
• Biology of lung cancer.

  1994cited by this paper
• Retinoblastoma protein expression in lung cancer: an immunohistochemical analysis.

  1994cited by this paper
• RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma.

  1994cited by this paper
• A cell cycle regulator potentially involved in genesis of many tumor types.

  1994cited by this paper
• Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer.

  1994cited by this paper
• P16 gene in uncultured tumours

  1994cited by this paper
• Colon cancer and DNA repair: have mismatches met their match?

  1994cited by this paper
• Mutations and altered expression of p16INK4 in human cancer.

  1994cited by this paper
• Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

  1994cited by this paper
• Tumour biology. p53, guardian of Rb.

  1994cited by this paper
• A comparison of the biological activities of wild‐type and mutant p53

  1993cited by this paper
• Antioncogenes and human cancer.

  1993cited by this paper
• Antioncogenes and human cancer.

  1993cited by this paper
• Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.

  1993cited by this paper
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

  1993cited by this paper
• Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome.

  1993cited by this paper
• Polymerase chain reaction microanalysis of tumors from stained histological slides.

  1992cited by this paper
• Negative regulation of Rb expression by the p53 gene product.

  1992cited by this paper
• Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas.

  1991cited by this paper
• Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total RB protein level.

  1991cited by this paper
• Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.

  1991cited by this paper
• Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines

  1990cited by this paper
• Basic methods in molecular biology

  1986cited by this paper
• The World Health Organization. Histological typing of lung tumours.

  1982cited by this paper
• The World Health Organization histological typing of lung tumours. Second edition.

  1982cited by this paper
• Mutations and altered expression of p 16 INK 4 in human cancer ( p 53 protein / tumor-suppressor gene / cyclin Di / retinoblastoma protein )

  year unknowncited by this paper

• Human Papillomavirus Is Rare and Does Not Correlate with p16INK4A Expression in Non-Small-Cell Lung Cancer in a Jordanian Subpopulation

  2024cites this paper
• MZF1 mediates oncogene-induced senescence by promoting the transcription of p16INK4A

  2021cites this paper
• The bright and dark side of skin senescence. Could skin rejuvenation anti-senescence interventions become a "bright" new strategy for the prevention of age-related skin pathologies?

  2020cites this paper
• DNA replication in progenitor cells and epithelial regeneration after lung injury requires the oncoprotein MDM2.

  2019cites this paper
• NeoTYPE TM Analysis Discovery Profile Client 1234 Sample Client

  2018cites this paper
• Integrating the DNA damage and protein stress responses during cancer development and treatment

  2018cites this paper
• Circulating anti‐p16a IgG autoantibodies as a potential prognostic biomarker for non‐small cell lung cancer

  2018cites this paper
• Expression of p16INK4a Protein in Colorectal Cancer Patients

  2017cites this paper
• Prognostic significance of overexpressed matrix metalloproteinase-2, mouse-double minute: 2 homolog and epidermal growth factor receptor in non-small cell lung cancer.

  2016cites this paper
• Prognostic value of p16 expression in Epstein‐Barr virus–positive nasopharyngeal carcinomas

  2016cites this paper
• Association of p53 and mdm2 in the development and progression of non-small cell lung cancer

  2015cites this paper
• Relationship of immunohistochemical biomarker expression and lymph node involvement in patients undergoing surgical treatment of NSCLC with long-term follow-up

  2014cites this paper
• HPV-associated lung cancers: an international pooled analysis.

  2014cites this paper
• Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples.

  2014cites this paper
• Lung Cancer Patients Cancer Cell Lines and Primary Cultures Freshly Made from ONYX-015 Works Synergistically with Chemotherapy in Lung

  2014cites this paper
• Schwannomas, benign tumors with a senescent phenotype.

  2014cites this paper
• Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer

  2013cites this paper
• Role of E3 ubiquitin ligases in lung cancer.

  2013cites this paper
• Detection of Transcriptionally Active High-risk HPV in Patients With Head and Neck Squamous Cell Carcinoma as Visualized by a Novel E6/E7 mRNA In Situ Hybridization Method

  2012cites this paper
• Molecular Markers with Predictive and Prognostic Relevance in Lung Cancer

  2012cites this paper
• Detection of Herplex Simplex Virus-1 and -2 in Cardiac Myxomas

  2012cites this paper
• HPV Analysis in Distinguishing Second Primary Tumors From Lung Metastases in Patients With Head and Neck Squamous Cell Carcinoma

  2012cites this paper
• Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins

  2011cites this paper
• p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors

  2011cites this paper
• Implication of p16 inactivation in tumorigenic activity of respiratory epithelial cell lines and adenocarcinoma cell line established from plutonium-induced lung tumor in rat

  2010cites this paper
• Exploring the Gain of Function Contribution of AKT to Mammary Tumorigenesis in Mouse Models

  2010cites this paper
• Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas.

  2009cites this paper
• Loss of Heterozygosity

  2009cites this paper
• Identification of New p53 Acetylation Sites in COS-1 Cells*

  2009cites this paper
• Loss of Heterozygosity in Lung Diseases

  2008cites this paper
• Molecular Characterization of Spontaneous Mesenchymal Stem Cell Transformation

  2008cites this paper
• Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53‐ and p16/Rb‐dependent cell cycle regulator proteins

  2008cites this paper
• Molecular Pathology of Squamous Cell Carcinoma and Its Precursors

  2008cites this paper
• Kliniczne znaczenie polimorfizmu Ser326Cys genu hOGG1 u chorych na niedrobnokomórkowego raka płuca (NDRP)

  2008cites this paper
• siRNA-mediated MDM2 inhibition sensitizes human lung cancer A549 cells to radiation.

  2007cites this paper
• Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non‐small cell lung cancer

  2007cites this paper
• Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer

  2006cites this paper
• Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population

  2006cites this paper
• Sequence variants in cell cycle control pathway, X-ray exposure, and lung cancer risk: a multicenter case-control study in Central Europe.

  2006cites this paper
• High rate of molecular alteration in histologically tumour-free bronchial epithelium of NSCLC patients detected by multicolour fluorescence in situ hybridisation.

  2006cites this paper
• Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation

  2006cites this paper
• Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas.

  2006cites this paper
• Downregulation of the KIP family members p27KIP1 and p57KIP2 by SKP2 and the role of methylation in p57KIP2 inactivation in nonsmall cell lung cancer

  2006cites this paper
• Mdm2-mediated pRB downregulation is involved in carcinogenesis in a p53-independent manner.

  2006cites this paper
• Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

  2005cites this paper
• Involvement of E2F transcription factor family in cancer.

  2005cites this paper
• Alterations of 9p in squamous cell carcinoma and adenocarcinoma of the lung: association with smoking, TP53, and survival.

  2005cites this paper
• MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy.

  2005cites this paper
• Changes in end products of nitric oxide in urine and induction of nitric oxide synthase expression in urinary bladder during intravesical instillations of IFN-alpha2b.

  2004cites this paper
• Biomarkers in non-small cell lung cancer prevention

  2004influential citation
• NC381, a Novel Anticancer Agent, Arrests the Cell Cycle in G0-G1 and Inhibits Lung Tumor Cell Growth in Vitro and in Vivo

  2004cites this paper
• CpG Island Methylation Is Responsible for p14ARF Inactivation and Inversely Correlates with p53 Overexpression in Resected Non–Small Cell Lung Cancer

  2004cites this paper
• Electron microscopy evidence that cytoplasmic localization of the p16INK4A “nuclear” cyclin-dependent kinase inhibitor (CKI) in tumor cells is specific and not an artifact. A study in non-small cell lung carcinomas

  2004cites this paper
• Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb

  2004cites this paper
• Distinct expression patterns of the transcription factor E2F‐1 in relation to tumour growth parameters in common human carcinomas

  2004cites this paper
• Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability--evidence of E2F-1 transcriptional control over hCdt1.

  2004cites this paper
• Changes in End Products of Nitric Oxide in Urine and Induction of Nitric Oxide Synthase Expression in Urinary Bladder During Intravesical Instillations of IFN-α2b

  2004cites this paper
• A NOVEL ANTICANCER AGENT , ARRESTS THE CELL CYCLE IN G 0G 1 AND INHIBITS LUNG TUMOR CELL GROWTH IN VITRO AND IN VIVO

  2003cites this paper
• Pharmacogenetics of Anticancer Drug Sensitivity in Non-Small Cell Lung Cancer

  2003cites this paper
• Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer.

  2003cites this paper
• In-depth analysis of molecular alterations within normal and tumour tissue from an entire bronchial tree.

  2003cites this paper
• Overexpression of p16INK4A and p14ARF in haematological malignancies.

  2003cites this paper
• Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays

  2003cites this paper
• Growth index is independent of microvessel density in non-small cell lung carcinomas.

  2003cites this paper
• Cell cycle modulators for the treatment of lung malignancies.

  2003cites this paper
• Cell Cycle Inhibitors in Cancer Therapy

  2003cites this paper
• Clinical significance of P16INK4A and retinoblastoma proteins in non-small-cell lung carcinoma.

  2002cites this paper
• Alterations of the p16ink4a gene in resected nonsmall cell lung tumors and exfoliated cells within sputum

  2002cites this paper
• Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin–Reed–Sternberg cells in Hodgkin's disease

  2002cites this paper
• Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators.

  2002influential citation
• Frequent Epigenetic Silencing of the p16 Gene in Non‐small Cell Lung Cancers of Tobacco Smokers

  2002cites this paper
• Growth index is independent of microvessel density in non-small-cell lung carcinomas.

  2002cites this paper
• Transcription factor E2F‐1 acts as a growth‐promoting factor and is associated with adverse prognosis in non‐small cell lung carcinomas

  2002cites this paper
• DNA methylation analysis: a powerful new tool for lung cancer diagnosis

  2002cites this paper
• Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in stage I adenocarcinomas of the lung

  2002cites this paper
• Genetic and epigenetic alterations of the INK4a–ARF pathway in cholangiocarcinoma

  2002cites this paper
• Prognostic factors in non-small cell lung carcinoma.

  2002cites this paper
• Absence of p53 gene mutations in skin fibroblasts derived from patients with systemic sclerosis

  2002cites this paper
• BAX and p16INK4A are independent positive prognostic markers for advanced tumour stage of nonsmall cell lung cancer

  2002cites this paper
• Mdm2 overexpression and p14ARF inactivation are two mutually exclusive events in primary human lung tumors

  2002cites this paper
• Altered expression of G1/S regulatory genes occurs early and frequently in lung carcinogenesis in transforming growth factor-beta1 heterozygous mice.

  2002cites this paper
• Bone Tumorigenesis Induced by Alpha-Particle Radiation: Mapping of Genetic Loci Influencing Predisposition in Mice

  2002cites this paper
• Metilación del gen p16 en el carcinoma broncogénico no microcítico. Implicación pronóstica Methylation of gene p16 in non-small cell bronchogenic carcinoma. Prognostic implication

  2002cites this paper
• Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).

  2001cites this paper
• Microsatellite alterations in patients with thoracic sarcoma.

  2001cites this paper
• Loss of p16 and/or pRb protein expression in NSCLC. An immunohistochemical and prognostic study.

  2001cites this paper
• Low Levels of p27 in Association With Deregulated p53-pRb Protein Status Enhance Tumor Proliferation and Chromosomal Instability in Non-Small Cell Lung Carcinomas

  2001cites this paper
• Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27.

  2001cites this paper
• Alterations of p 14 ARF , p 53 , and p 73 Genes Involved in the E 2 F-1-mediated Apoptotic Pathways in Non-Small Cell Lung Carcinoma

  2001cites this paper
• Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene

  2001cites this paper
• Additional characterization of a hexanucleotide polymorphic site in the first intron of human H-ras gene: comparative study of its alterations in non-small cell lung carcinomas and sporadic invasive breast carcinomas.

  2001cites this paper
• Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer.

  2001cites this paper
• Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma.

  2001cites this paper
• Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.

  2001cites this paper
• Prognostic significance of percentage of bronchioloalveolar pattern in adenocarcinomas of the lung.

  2001cites this paper
• Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas.

  2001cites this paper
• Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China.

  2001cites this paper
• Prognostic Implications of Aberrations in p16/pRb Pathway in Urothelial Bladder Carcinomas: A Multivariate Analysis Including p53 Expression and Proliferation Markers

  2001cites this paper
• Aberrant Expression of pRb, p16, p14ARF, MDM2, p21 and p53 in Squamous Cell Carcinomas of Lung

  2001cites this paper
• Valor pronóstico de la pérdida de heterozigosidad en la región 9p21 en el carcinoma broncogénico no microcítico

  2001cites this paper